Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jul 11;18(7):e0288672. doi: 10.1371/journal.pone.0288672

Correction: miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6

Weiwei Jiang, Liangliang Kong, Qingfeng Ni, Yeting Lu, Wenzhou Ding, Guoqing Liu, Liyong Pu, Weibing Tang, Lianbao Kong
PMCID: PMC10335655  PMID: 37432933

Following the publication of this article [1], concerns were raised regarding results presented in Fig 6. Specifically, the Fig 6D Ago-mir-146a panel appeared similar to the Fig 6G Ago-mir-146a panel despite being used to represent different experimental conditions.

Fig 6. Transfection of Ago-miR-146a reduces liver ischemia/reperfusion injury in vivo.

Fig 6

(A) Male mice (n  =  3–4 mice per group) were treated with Ago-mir-146a, its control or vector for 24 h, qPCR analysis of mature miR-146a. With the same transfection, mice (n  =  8–10 mice per group) were then subjected to I/R. (B) The mRNA and protein levels of IRAK1 and TRAF6 were determined by qPCR and Western Blot, respectively. (C) serum TNF-α were determined by ELISA. (D) Representive Immunohistochemistry staining and IHC scores of liver tissue for NF-κB p65 (magnification 200×). (E) Representive H&E staining (magnification ×200 and ×400 (inset)) and Suzuki’s grades. (F) serum ALT and AST. (G) TUNEL staining of hepatocellular apoptosis (magnification ×200 and ×400 (inset)). Results are mean ± SD. *, P<0.05 and **,P<0.01,***,P<0.001 versus negative control.

The corresponding author explained that during the initial rounds of revision of this manuscript the incorrect images were accidentally used to prepare the Fig 6D panel. They provided an updated Fig 6 with the correct Fig 6D Ago-mir-146a image obtained in the original experiment, as well as the individual level data underlying the published results (S1 File).

Editorial review of these data raised concerns that the underlying data presented for Fig 6C presents 10 Ago-mir-NC samples and 8 Ago-mir-146a samples, whereas the underlying data for Figs 6D, 6E, and 6F all present 8 Ago-mir-NC samples and 10 Ago-mir-146a samples. The corresponding author explained that 10 mice were used in each group whilst performing liver ischemia/reperfusion experiments, but that two liver samples of the Ago-mir-NC group were damaged during embedding or sectioning, and as a result this group only contained 8 samples. The Fig 6C results present ELISA data obtained from serum samples; authors intended to match sample sizes for this experiment and Figs 6D–6F, but instead conducted the Fig 6C experiment with n = 8 samples in the Ago-mir-146a and n = 10 samples in the Ago-mir-NC group. The corresponding author stated that the data shown in the figure are correctly labelled as to the experimental groups.

Supporting information

S1 File. Individual level data underlying the Fig 6A–6G results.

(ZIP)

S2 File. Original western blot data underlying the Fig 6B results.

(ZIP)

Reference

  • 1.Jiang W, Kong L, Ni Q, Lu Y, Ding W, Liu G, et al. (2014) miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6. PLoS ONE 9(7): e101530. 10.1371/journal.pone.0101530 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Individual level data underlying the Fig 6A–6G results.

(ZIP)

S2 File. Original western blot data underlying the Fig 6B results.

(ZIP)


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES